The Influence of Diet and Probiotics on the Response of Solid Tumours to Immunotherapy: Present and Future Perspectives
Source abstract
Abstract
Currently, various immunotherapeutic treatments are revolutionizing therapies that treat solid neoplasms. For these treatments, within immunotherapy, immune checkpoint inhibitors (ICIs) are the most widely used drugs. Diverse studies have shown the influence of diet and probiotics on the response to ICIs and consequently on the survival rates associated with different neoplasms. The use of various antibiotics, probiotics, and prebiotics has been associated with changes in the gut microbiota, and this, in turn, with resistance to immunotherapy. Together with the above, a lower intake of red meat and greater consumption of a Mediterranean, vegetarian, or vegan diet have led to a new way of understanding the mechanisms of resistance to ICIs. Omega-3 and polyphenol supplements are also powerful regulators of the microbiome whose influence on the immune system. Therefore, this review covers the influence of diet and probiotics on the response to immunotherapy in patients who have solid tumours.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Gut microbiota and health · Probiotics and Fermented Foods · Helicobacter pylori-related gastroenterology studies
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Medical Oncology, University Hospital of Salamanca, 37007 Salamanca, Spain
Institute for Biomedical Research of Salamanca (IBSAL), 37007 Salamanca, Spain
Department of Internal Medicine, Hospital Virgen del Rocío, 41013 Sevilla, Spain
Department of Internal Medicine, University Hospital Rio Hortega, 47012 Valladolid, Spain
Department of Medicine, University of Valladolid, 45005 Valladolid, Spain
References (59)
Show source-provided references
1. Gut microbiota in human metabolic health and disease10.1038/s41579-020-0433-9 ↗
2. Linking gut microbiota with the human diseases10.6026/97320630016196 ↗
3. Diversity and functional landscapes in the microbiota of animals in the wild10.1126/science.abb5352 ↗
4. Introduction to the human gut microbiota10.1042/BCJ20160510 ↗
5. Detection of bacteria in placental tissues obtained from extremely low gestational age neonates10.1016/j.ajog.2007.05.044 ↗
6. Dietary fiber and prebiotics and the gastrointestinal microbiota10.1080/19490976.2017.1290756 ↗
7. Hills, R.D., Pontefract, B.A., Mishcon, H.R., Black, C.A., Sutton, S.C., and Theberge, C.R. (2019). Gut microbiome: Profound implications for diet and disease. Nutrients, 11.10.3390/nu11071613 ↗
8. How Western Diet And Lifestyle Drive The Pandemic Of Obesity And Civilization Diseases10.2147/DMSO.S216791 ↗
9. Shi, Z. (2019). Gut Microbiota: An Important Link between Western Diet and Chronic Diseases. Nutrients, 11.10.3390/nu11102287 ↗
10. The effect of diet on the human gut microbiome: A meta-genomic analysis in humanized gnotobiotic mice10.1126/scitranslmed.3000322 ↗
11. Faculty Opinions recommendation of Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa
12. The role of gut microbiota in immune homeostasis and autoimmunity10.4161/gmic.19320 ↗
13. Exploring the food-gut axis in immunotherapy response of cancer patients10.3748/wjg.v26.i33.4919 ↗
14. Surface area of the digestive tract—Revisited10.3109/00365521.2014.898326 ↗
15. Regulation of intestinal permeability: The role of proteases10.3748/wjg.v23.i12.2106 ↗
16. Gut Bacteria in Health and Disease
17. Wang, S., Hibberd, M.L., Pettersson, S., and Lee, Y.K. (2014). Enterococcus faecalis from Healthy Infants Modulates Inflammation through MAPK Signaling Pathways. PLoS ONE, 9.10.1371/journal.pone.0097523 ↗
18. Intestinal IgA production and its role in host-microbe interaction10.1111/imr.12189 ↗
19. The Role of the interleukin-10 Subfamily Members in Immunoglobulin Production by Human B Cells10.1111/j.1365-3083.2006.01773.x ↗
20. Microbiota in T-cell homeostasis and inflammatory diseases10.1038/emm.2017.36 ↗
21. Early-life gut microbial colonization shapes Th1/Th2 balance in asthma model in BALB/c mice10.1186/s12866-017-1044-0 ↗
22. Meta-analysis of the gut microbiota in predicting response to cancer immuno-therapy in metastatic melanoma10.1172/jci.insight.140940 ↗
23. Barber, T.M., Kabisch, S., Pfeiffer, A.F.H., and Weickert, M.O. (2020). The Health Benefits of Dietary Fibre. Nutrients, 12.10.3390/nu12103209 ↗
24. A review of probiotic supplementation in healthy adults: Helpful or hype?10.1038/s41430-018-0135-9 ↗
25. Incorporation of Propionibacteria in Fermented Milks as a Probiotic10.1080/10408398.2013.766584 ↗
26. Kefir: A powerful probiotics with anticancer properties10.1007/s12032-017-1044-9 ↗
27. Colorectal Cancer and Nonfermented Milk, Solid Cheese, and Fermented Milk Consumption: A Systematic Review and Meta-Analysis of Prospective Studies10.1080/10408398.2011.629353 ↗
28. The controversial role of Enterococcus faecalis in colorectal cancer
29. Gut Microbiome as a Potential Factor for Modulating Resistance to Cancer Im-munotherapy10.3389/fimmu.2019.02989 ↗
30. Diet and inflammation10.1177/0884533610385703 ↗
31. Dietary Patterns and Risk of Colorectal Cancer: Analysis by Tumor Location and Molecular Subtypes10.1053/j.gastro.2017.02.015 ↗
32. The Mediterranean Diet, its Components, and Cardiovascular Disease10.1016/j.amjmed.2014.10.014 ↗
33. Mentella, M.C., Scaldaferri, F., Ricci, C., Gasbarrini, A., and Miggiano, G.A.D. (2019). Cancer and Mediterranean Diet: A Review. Nutrients, 11.10.3390/nu11092059 ↗
34. Mediterranean Diet and Cardiovascular Prevention10.1016/j.recesp.2013.04.026 ↗
35. Targeting nucleotide metabolism as the nexus of viral infections, cancer, and the immune response10.1126/sciadv.abg6165 ↗
36. Randomized clinical trial of perioperative omega-3 fatty acid supplements in elective colorectal cancer surgery10.1002/bjs.9361 ↗
37. The ketogenic diet inhibits the mammalian target of rapamycin (mTOR) pathway10.1111/j.1528-1167.2011.02981.x ↗
38. Ketogenic diet: A role in immunity?10.15844/pedneurbriefs-34-5 ↗
39. Current explorations of nutrition and the gut microbiome: A comprehensive evaluation of the review literatura10.1093/nutrit/nuz106 ↗
40. Diet-induced obesity has a differential effect on adipose tissue and macrophage inflammatory responses of young and old mice10.1002/biof.1075 ↗
41. Bifidobacteria or Fiber Protects against Diet-Induced Microbiota-Mediated Colonic Mucus Deterioration10.1016/j.chom.2017.11.004 ↗
42. Dietary therapy for clostridium difficile colonization: A case series10.1016/j.anaerobe.2019.02.016 ↗
43. The toxins of William, B. Coley and the treatment of bone and soft-tissue sarcomas
44. Immunotherapy: Enhancing the efficacy of this promising therapeutic in multiple can-cers10.1042/CS20181003 ↗
45. CTLA-4: A moving target in immunotherapy10.1182/blood-2017-06-741033 ↗
46. PD-L110.1136/jclinpath-2017-204853 ↗
47. Predictive biomarkers for response to immune checkpoint inhibitors in lung cancer: PD-L1 and beyond10.1007/s00428-021-03030-8 ↗
48. Mechanisms and microbial influences on CTLA-4 and PD-1-based immunotherapy in the treatment of cancer: A narrative review10.1186/s13099-020-00381-6 ↗
49. Fecal microbiota transplantation: Can it circumvent resistance to PD-1 blockade in melanoma?
50. Role of the gut microbiome for cancer patients receiving immunotherapy: Dietary and treatment implications10.1016/j.ejca.2020.07.026 ↗
51. Trial watch: Dietary interventions for cancer therapy10.1080/2162402X.2019.1591878 ↗
52. Diet rapidly and reproducibly alters the human gut microbiome10.1038/nature12820 ↗
53. Myhrstad, M.C.W., Tunsjo, H., Charnock, C., and Telle-Hansen, V.H. (2020). Dietary fiber, gut microbiota, and metabolic regulation-current status in human randomized trials. Nutrients, 12.10.3390/nu12030859 ↗
54. The Treg/Th17 Axis: A Dynamic Balance Regulated by the Gut Microbiome10.3389/fimmu.2015.00639 ↗
55. Immunotherapy Toxicity10.1016/j.hoc.2018.12.008 ↗
56. Clinical Characteristics and Treatment of Immune-Related Adverse Events of Immune Checkpoint Inhibitors10.4110/in.2020.20.e9 ↗
57. The interplay of obesity, gut microbiome and diet in the immune check point inhibitors therapy era10.1016/j.semcancer.2021.05.008 ↗
58. Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota10.1126/science.aad1329 ↗
59. Baseline gut microbiota predicts clinical response and colitis in metastatic melanoma patients treated with ipilimumab10.1093/annonc/mdx108 ↗